Friday, May 4, 2018
Experimental Ovarian Cancer Screening Test
The article describes a new screening tool being studied to detect endometrial and ovarian cancer in its early stages.
Called PapSEEK, this liquid biopsy is actually a PAP test that checks for cancer related DNA changes. Preliminary investigations showed that it detected 33% of ovarian cancers (of which 34% were detected in early stages) and ~81% of endometrial cancers (of which 78% were detected in early stages).
These results were first published in the journal Science: Translational Medicine and was reported on the National Cancer Institute web site. Follow this link to read NCI's article.